Tumor de Células de Leydig num Doente com Criptorquidia Contralateral: Uma Associação Rara

Ricardo Capitão; Catarina Saraiva; Clara Cunha; Mónica Martins

doi:10.20344/amp.11882

Leydig Cell Tumor in a Patient with Contralateral Cryptorchidism: A Rare Association

Authors

Ricardo Capitão Serviço de Endocrinologia. Hospital Egas Moniz. Lisboa. https://orcid.org/0000-0001-6868-0071
Catarina Saraiva Serviço de Endocrinologia. Hospital Egas Moniz. Lisboa.
Clara Cunha Serviço de Endocrinologia. Hospital Egas Moniz. Lisboa.
Mónica Martins Unidade de Saúde Familiar do Dafundo. Lisboa.

DOI:

https://doi.org/10.20344/amp.11882

Keywords:

Cryptorchidism, Gynecomastia, Leydig Cell Tumor, Testicular Neoplasms

Abstract

Gynecomastia is a frequent sign that may be physiological or caused by various benign or malignant diseases. In rare cases, it may be caused by testicular tumors. We describe a case of progressive gynecomastia at age 20 due to a Leydig cell tumor of the right testicle in a patient with a previous history of left-sided cryptorchidism. The patient underwent orchidectomy and testicular prosthesis placement, with subsequent improvement of gynecomastia and normalization of estrogen. Our case, in addition to demonstrating that gynecomastia may regress if the underlying cause is treated in a timely manner, shows that cryptorchidism may be related with the development of Leydig cell tumors in the same way as it is in other testicular tumors.

Downloads

Download data is not yet available.

Downloads

PDF (Português)

Published

2021-02-01

How to Cite

Capitão R, Saraiva C, Cunha C, Martins M. Leydig Cell Tumor in a Patient with Contralateral Cryptorchidism: A Rare Association. Acta Med Port [Internet]. 2021 Feb. 1 [cited 2024 Apr. 24];34(2):137-9. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11882

Download Citation

Issue

Vol. 34 No. 2 (2021): February

Section

Case Report

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.